When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
HRTX - Heron Therapeutics readies mid-stage study of aprepitant for COVID-19
Heron Therapeutics Inc.
Heron Therapeutics (HRTX+3.3%) perks up on average volume in apparent response to the posting in ClinicalTrials.gov of a Phase 2 clinical trial, GUARDS-1, evaluating aprepitant in early hospitalized adult COVID-19 patients.
More news on: Heron Therapeutics, Inc., Healthcare stocks news, Stocks on the move,